Placebo News and Research

RSS

Project Ubuzima to continue trials of microbicide Dapirivine

Project Ubuzima, an international not-for-profit group conducting clinical trials of microbicides, last week "assured the public" it will continue its trial of the microbicide Dapirivine in Rwanda, the New Times/AllAfrica.com reports.

22 Feb 2007

Tamoxifen offers long-term benefits for breast cancer prevention among women at high risk

The trials found that the breast cancer risk reduction persists long after women stop taking tamoxifen.

20 Feb 2007

Drug montelukast reduces trips to doctor for childhood asthma attacks

Young children with attacks of sporadic, recurring asthma who were treated with the prescription drug montelukast by their parents had fewer unscheduled trips to the doctor, missed less days from school or childcare, and caused their parents to take fewer days off work for their care.

15 Feb 2007

Slow-release morphine helps chronic persistent cough

Slow-release morphine helped a group of patients with long-term, treatment-resistant chronic cough reduce their daily cough score levels by 40 percent.

15 Feb 2007

Marijuana gives relief from chronic pain for AIDS sufferers

Researchers have found that people suffering from chronic foot pain as a result of the AIDS virus gained relief from smoking marijuana.

14 Feb 2007

Treating child ailments with garlic, caution!

Parents and practitioners should know more about garlic before using it to treat children, according to a review of data conducted in part by the University of Alberta.

13 Feb 2007

Mood changes in response to psychosocial stress in healthy young women: effects of pretreatment with Cortisol

German researchers have found additional evidence that the stress hormone cortisol can have positive effects in certain situations.

12 Feb 2007

South Africa starts major HIV/AIDS vaccine trial

The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.

11 Feb 2007

Risk of developing diabetes increasingly involved in decisions regarding HRT

Although doctors for years have "talked about the health effects of hormones on bones, breasts and women's hearts," diabetes has not been "part of the debate" until last week, when the North American Menopause Society in a revised position statement said that women taking hormone replacement therapy appear to be less likely to develop the disease, the Wall Street Journal reports.

7 Feb 2007

Antipodean Pharma commences phase 2 trial in hepatitis C

Antipodean Pharmaceuticals has announced it has initiated a Phase 2 clinical trial of its lead compound MitoQ (mitoquinone) to investigate the drug's efficacy to reduce liver damage in patients with raised liver enzymes associated with the Hepatitis C virus (HCV).

5 Feb 2007

Cellulose sulfate microbicide stopped

A Phase III study of the candidate microbicide cellulose sulfate to prevent HIV transmission in women has been stopped prematurely because of a higher number of HIV infections in the active compared with the placebo group.

31 Jan 2007

Garlic offers hope in cystic fibrosis infection

Garlic has been hailed a wonder drug for centuries and has been used to prevent gangrene, treat high blood pressure, ward off common colds and is even believed by some to have cancer-fighting properties.

31 Jan 2007

FDA approves Neuren's phase 3 Glypromate trial

Neuren Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) and authorised the Company to proceed with its Phase 3 trial to prevent cognitive impairment following major cardiac surgery using Glypromate.

30 Jan 2007